Relevant bibliographies by topics / Autoimmune system; Muscle

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters

Academic literature on the topic 'Autoimmune system; Muscle'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Autoimmune system; Muscle.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Autoimmune system; Muscle"

1

Sweeney, Michael. "Autoimmune Neurologic Diseases in Children." Seminars in Neurology 38, no. 03 (2018): 355–70. http://dx.doi.org/10.1055/s-0038-1660520.

Full text
Abstract:
AbstractAutoimmune diseases of the nervous system in children are composed of a heterogeneous group of rare disorders that can affect the central or peripheral nervous system at any level. Presentations may occur in children of any age and are typically acute or subacute in onset. Consideration of an autoimmune process as the etiology of neurologic diseases in children is important, as it may lead to early initiation of immunotherapy and an improvement in long-term neurologic outcomes. The developing nervous and immune systems in children create unique challenges in diagnosis and treatment of
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Tan, Xin Feng, Bo Feng, et al. "CARDIAC TROPONIN T MEDIATED AUTOIMMUNE RESPONSE AND ITS ROLE IN SKELETAL MUSCLE AGING." Innovation in Aging 3, Supplement_1 (2019): S882. http://dx.doi.org/10.1093/geroni/igz038.3231.

Full text
Abstract:
Abstract Cardiac troponin T (cTnT), a key component of contractile machinery essential for muscle contraction, is also expressed in skeletal muscle under certain conditions (e.g. neuromuscular diseases and aging). We have reported that skeletal muscle cTnT regulates neuromuscular junction denervation preferentially in fast skeletal muscle of old mice. Here, we further report that cTnT is also enriched within some myofibers, and/or along microvascular walls in old mice fast skeletal muscle. Strikingly, immunoglobulin G (IgG), together with markers of complement system activation, cell death (ne
APA, Harvard, Vancouver, ISO, and other styles
3

Mathis, Stéphane, Laurent Magy, Philippe Corcia, et al. "Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome." Case Reports in Neurological Medicine 2016 (2016): 1–11. http://dx.doi.org/10.1155/2016/6108234.

Full text
Abstract:
Immune-mediated neuromuscular disorders include pathologies of the peripheral nervous system, neuromuscular junction, and muscles. If overlap syndromes (or the association of almost two autoimmune disorders) are recognized, the simultaneous occurrence of several autoimmune neuromuscular disorders is rare. We describe two patients presenting the simultaneous occurrence of inflammatory neuropathy, myositis, and myasthenia gravis (with positive acetylcholine receptor antibodies). For each patient, we carried out a pathological analysis (nerve and muscle) and an electrophysiological study (and fol
APA, Harvard, Vancouver, ISO, and other styles
4

Jacob, Saiju. "Myasthenia Gravis – A Review of Current Therapeutic Options." European Neurological Review 13, no. 2 (2018): 86. http://dx.doi.org/10.17925/enr.2018.13.2.86.

Full text
Abstract:
Myasthenia gravis (MG) is an autoimmune disorder that leads to skeletal muscle weakness and fatigue. The autoimmune attack is caused by autoantibodies against the acetylcholine postsynaptic receptors at the neuromuscular junction of skeletal muscles. However, other antigenic targets that are components of the neuromuscular junction have also been implicated in the pathogenesis of MG. The current standard of care is immunosuppressive therapy; however, many existing therapeutic options have not been validated for use in MG in large randomised controlled trials. Furthermore, around 10% of patient
APA, Harvard, Vancouver, ISO, and other styles
5

Amaya-Amaya, Jenny, Laura Montoya-Sánchez, and Adriana Rojas-Villarraga. "Cardiovascular Involvement in Autoimmune Diseases." BioMed Research International 2014 (2014): 1–31. http://dx.doi.org/10.1155/2014/367359.

Full text
Abstract:
Autoimmune diseases (AD) represent a broad spectrum of chronic conditions that may afflict specific target organs or multiple systems with a significant burden on quality of life. These conditions have common mechanisms including genetic and epigenetics factors, gender disparity, environmental triggers, pathophysiological abnormalities, and certain subphenotypes. Atherosclerosis (AT) was once considered to be a degenerative disease that was an inevitable consequence of aging. However, research in the last three decades has shown that AT is not degenerative or inevitable. It is an autoimmune-in
APA, Harvard, Vancouver, ISO, and other styles
6

Troshina, Ekaterina A., Elena A. Panfilova, and Taras S. Panevin. "Autoimmune polyglandular disorders in myotonic dystrophy." Problems of Endocrinology 65, no. 3 (2019): 155–60. http://dx.doi.org/10.14341/probl9775.

Full text
Abstract:
Myotonic dystrophy (MD) is the most common muscle disorder in adults. MD is a hereditary disease with an autosomal dominant mode of inheritance, almost 100% penetrance and pronounced clinical polymorphism. The mechanism for the development of the disease is that a mutation of the DMPK (dystrophia myotonica protein kinase) gene disrupts the normal metabolism of RNA, which leads to a defect in the maturation and translation of mRNA. The disorder in the DMPK gene affects not only striated musculature, but also smooth myocytes and cardiomyocytes. The main clinical symptom that distinguishes MD fro
APA, Harvard, Vancouver, ISO, and other styles
7

Shidlovskyi, V. O., O. V. Shidlovskyi, and V. V. Kravtsiv. "The effect of autoimmune thyroiditis on the organs and systems of the body (a literature review)." INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 17, no. 2 (2021): 145–54. http://dx.doi.org/10.22141/2224-0721.17.2.2021.230569.

Full text
Abstract:
Background. In recent years, scientific reports on the effects of autoimmune thyroiditis on the body have been published. They concern separate organs and systems that does not allow receiving the general picture of pathological reactions of the body to autoimmune aggression. The review analyzes the literature sources about the pathological significance of autoimmune thyroiditis for the body as a whole. Sources of information. The sources of information were reports in domestic and, mainly, fo­reign periodicals on general medicine, pathophysiology, immuno­logy, and endocrinology. Synthesis of
APA, Harvard, Vancouver, ISO, and other styles
8

Pejin, Radoslav, Edita Stokic, Mile Novkovic, Sofija Banic-Horvat, and Milan Cvijanovic. "Autoimmune polyglandular syndrome, type 2 associated with myasthenia gravis." Vojnosanitetski pregled 69, no. 4 (2012): 358–62. http://dx.doi.org/10.2298/vsp1204358p.

Full text
Abstract:
Introduction. Autoimmune polyglandular syndrome type 2 is defined as adrenal insufficiency associated with autoimmune primary hypothyroidism and/or with autoimmune type 1 diabetes mellitus, but very rare with myasthenia gravis. Case report. We presented a case of an autoimmune polyglandular syndrome, type 2 associated with myasthenia gravis. A 49-year-old female with symptoms of muscle weakness and low serum levels of cortisol and aldosterone was already diagnosed with primary adrenal insufficiency. Primary hypothyroidism was identified with low values of free thyroxine 4 (FT4) and raised valu
APA, Harvard, Vancouver, ISO, and other styles
9

Hristov, K. "OBESITY, INFLAMMATION, AND T-CELL METABOLISM." Trakia Journal of Sciences 17, no. 4 (2019): 392–98. http://dx.doi.org/10.15547/tjs.2019.04.017.

Full text
Abstract:
Aim: The overview of the interdependence of the immune system and the system metabolism. Regulation of metabolism is immunomodulatory, and targeting key cellular metabolic enzymes impacts T-cell development, altering the immune functions. Background: The diet, gastrointestinal microbiota and the balanced function of liver, adipose and muscle tissues underlie the immune ecology. Chronic inflammation (macrophage, TH1, and TH17 T-cell infiltration) associates with obesity, and the development of metabolic syndrome, cardiovascular diseases, type 2 diabetes, IBD and intestinal malignancies. While n
APA, Harvard, Vancouver, ISO, and other styles
10

Váncsa, Andrea, and Katalin Dankó. "Újabb adatok a myositisspecifikus és -asszociált antitestekről juvenilis és felnőttkori myositisekben." Orvosi Hetilap 157, no. 30 (2016): 1179–84. http://dx.doi.org/10.1556/650.2016.30404.

Full text
Abstract:
Myositis, which means inflammation of the muscles, is a general term used for inflammatory myopathies. Myositis is a rare idiopathic autoimmune disease. It is believed that environmental factors such as virus, bacteria, parasites, direct injuries, drugs side effect can trigger the immune system of genetically susceptible individuals to act against muscle tissues. There are several types of myositis with the same systemic symptoms such as muscle weakness, fatigue, muscle pain and inflammation. These include dermatomyositis, juvenile dermatomyositis, inclusion-body myositis, polymyositis, orbita
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Autoimmune system; Muscle"

1

Plested, Charles Paul. "Mechanism of action of seronegative myasthenia gravis." Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.301392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chan, Koon-ho. "Neuronal and muscle autoantibodies in paraneoplastic neurological disorders and autoimmune myasthenia gravis." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/HKUTO/record/B39557091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chan, Koon-ho, and 陳灌豪. "Neuronal and muscle autoantibodies in paraneoplastic neurological disorders and autoimmune myasthenia gravis." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39557091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hayashi, Ana Paula Tanaka. "Eficácia e segurança da suplementação de creatina em pacientes com lúpus erimatoso sistêmico de início juvenil." Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/5/5164/tde-07022014-144017/.

Full text
Abstract:
Introdução: A suplementação de creatina tem surgido na literatura como uma potencial estratégia terapêutica não farmacológica em diversas condições caracterizadas por disfunções musculares e baixa massa muscular, incluindo as doenças reumatológicas pediátricas. O objetivo deste estudo foi avaliar a eficácia e a segurança da suplementação de creatina em pacientes com lúpus eritematoso sistêmico de início juvenil (LESJ). Métodos: Trata-se de um estudo duplo-cego, crossover, balanceado e controlado por placebo. Os voluntários (n = 15) foram randomizados em duas condições que receberam creatina ou
APA, Harvard, Vancouver, ISO, and other styles
5

Barnes, Jill Nicole. "The effects of acute muscle damage and autoimmune disease on vascular function : the potential role of inflammation." 2009. http://hdl.handle.net/2152/6529.

Full text
Abstract:
Inflammation has been implicated in the development of cardiovascular disease and a potential underlying mechanism in the pathogenesis of impaired vascular function. Two different but complementary approaches were utilized to determine the role of inflammation on vascular function. First, to evaluate the effect of acute inflammation, we induced muscle damage to both small and large muscle mass and measured vascular function every 24 hours for up to 5 days of recovery. Eccentric exercise-induced muscle damage, in both small and large muscle mass, resulted in a transient increase in central arte
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Autoimmune system; Muscle"

1

Straub, Rainer H. Neuroendocrine system. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0022.

Full text
Abstract:
Endocrine abnormalities are very common in patients with chronic autoimmune rheumatic diseases (CARDs) due to the systemic involvement of the central nervous system and endocrine glands. In recent years, the response of the endocrine (and also neuronal) system to peripheral inflammation has been linked to overall energy regulation of the diseased body and bioenergetics of immune cells. In CARDs, hormonal and neuronal pathways are outstandingly important in partitioning energy-rich fuels from muscle, brain, and fat tissue to the activated immune system. Neuroendocrine regulation of fuel allocat
APA, Harvard, Vancouver, ISO, and other styles
2

Straub, Rainer H. Neuroendocrine system. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0022_update_002.

Full text
Abstract:
Endocrine abnormalities are very common in patients with chronic autoimmune rheumatic diseases (CARDs) due to the systemic involvement of the central nervous system and endocrine glands. In recent years, the response of the endocrine (and also neuronal) system to peripheral inflammation has been linked to overall energy regulation of the diseased body and bioenergetics of immune cells. In CARDs, hormonal and neuronal pathways are outstandingly important in partitioning energy-rich fuels from muscle, brain, and fat tissue to the activated immune system. Neuroendocrine regulation of fuel allocat
APA, Harvard, Vancouver, ISO, and other styles
3

Straub, Rainer H. Neuroendocrine system. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199642489.003.0022_update_003.

Full text
Abstract:
Endocrine abnormalities are very common in patients with chronic autoimmune rheumatic diseases (CARDs) due to the systemic involvement of the central nervous system and endocrine glands. In recent years, the response of the endocrine (and also neuronal) system to peripheral inflammation has been linked to overall energy regulation of the diseased body and bioenergetics of immune cells. In CARDs, hormonal and neuronal pathways are outstandingly important in partitioning energy-rich fuels from muscle, brain, and fat tissue to the activated immune system. Neuroendocrine regulation of fuel allocat
APA, Harvard, Vancouver, ISO, and other styles
4

Cohen, Jeffrey A., Justin J. Mowchun, Victoria H. Lawson, and Nathaniel M. Robbins. A 68-Year-Old Female with Progressive Pain and Weakness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190491901.003.0027.

Full text
Abstract:
Statin myopathy can occur at anytime during use. This chapter discusses an approach to diagnosis, and emphasizes management considerations, including awareness of statin metabolism by the cytochrome P-450 system. A statin must be discontinued in any patient with evidence of myopathy or myalgias. A muscle biopsy should be done in cases that do not improve clinically or by creatine kinase level. It is important to note that there are cases of apparent statin myopathy which transform into a chronic autoimmune inflammatory myopathy. Antibodies to hydroxymethylglutaryl coenzyme A (HMG-CoA) reductas
APA, Harvard, Vancouver, ISO, and other styles
5

Mills, Gary H. Pulmonary disease and anaesthesia. Edited by Philip M. Hopkins. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0082.

Full text
Abstract:
Respiratory adverse events are the commonest complications after anaesthesia and have profound implications for the recovery of the patient and their subsequent health. Outcome prediction related to respiratory disease and complications is vital when determining the risk:benefit balance of surgery and providing informed consent. Surgery produces an inflammatory response and pain, which affects the respiratory system. Anaesthesia produces atelectasis, decreases the drive to breathe, and causes muscle weakness. As the respiratory system ages, closing capacity increases and airway closure becomes
APA, Harvard, Vancouver, ISO, and other styles
6

Christadoss, Premkumar. Myasthenia Gravis: Disease Mechanism And Immunointervention. Alpha Science International, Ltd, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Christadoss, Premkumar. Myasthenia Gravis: Disease Mechanism and Immunointervention. Springer, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Limaye, Vidya Sadanand. Overview and epidemiology. Edited by Hector Chinoy and Robert Cooper. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198754121.003.0001.

Full text
Abstract:
The term idiopathic inflammatory myopathies (IIM) encompasses a heterogeneous group of muscle-dominant systemic autoimmune syndromes, including polymyositis (PM), dermatomyositis (DM), sporadic inclusion body myositis (sIBM), and immune-mediated necrotizing myopathy (IMNM). The reported incidence of IIM ranges from 5 to 10 × 10–6. Patients with PM, DM, and IMNM characteristically present with the insidious onset of symmetric proximal weakness, while in sIBM the weakness can be asymmetric, and involve the distal upper limbs and quadriceps. Dermatomyositis may also be accompanied by a range of c
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Autoimmune system; Muscle"

1

Guttmann, Oliver P., and Perry Elliott. "Specific heart muscle disorders." In Oxford Textbook of Medicine, edited by Jeremy Dwight. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0355.

Full text
Abstract:
Systemic immune-mediated diseases are autoimmune and autoinflammatory diseases affecting at least two-organ systems. Autoinflammatory diseases are a family of conditions characterized by episodes of unprovoked inflammation in the absence of high autoantibody titres or autoreactive T lymphocytes, reflecting a primary dysfunction of the innate immune system. Autoimmune diseases are characterized by aberrant B, T, and dendritic cell responses with predominantly cell-mediated or autoantibody-mediated responses to self-antigens in genetically susceptible individuals. Cardiovascular involvement is systemic immune-mediated diseases may be occult and often goes undetected, but is associated with a poor prognosis. As any anatomical structure in the heart may be involved, patients can present with one or more features consistent with pericarditis, myocarditis, endocarditis, and vasculitis. There is often no correlation between the extent of systemic disease and cardiac involvement.
APA, Harvard, Vancouver, ISO, and other styles
2

Shibasaki, Hiroshi, Mark Hallett, Kailash P. Bhatia, Stephen G. Reich, and Bettina Balint. "Disorders of Increased Muscle Stiffness or Overactivity." In Involuntary Movements. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190865047.003.0009.

Full text
Abstract:
Increased muscle stiffness or overactivity (which differs from parkinsonian rigidity or dystonia) can be caused by a variety of disorders of central or peripheral nervous system origin and genetic, autoimmune, or infectious etiology. Increased muscle stiffness may be the cause of some joint movements, particularly when such stiffness is associated with stimulus sensitivity that causes involuntary movements. The conditions discussed in this chapter include stiff person syndrome, progressive encephalomyelitis with rigidity and myoclonus (PERM), acquired neuromyotonia (Isaacs syndrome), hereditary neuromyotonia, tetanus (which has an infectious etiology), Satoyoshi disease, neuromyotonia, and rippling muscle disease. Many of these cases are caused by decreased synaptic inhibition through an autoimmune mechanism.
APA, Harvard, Vancouver, ISO, and other styles
3

Straub, Rainer H. "Neuroendocrine system and chronic autoimmune rheumatic diseases." In Oxford Textbook of Rheumatology. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0022_update_004.

Full text
Abstract:
Endocrine abnormalities are very common in patients with chronic autoimmune rheumatic diseases (CARDs) due to the systemic involvement of the central nervous system and endocrine glands. In recent years, the response of the endocrine (and also neuronal) system to peripheral inflammation has been linked to overall energy regulation of the diseased body and bioenergetics of immune cells. In CARDs, hormonal and neuronal pathways are outstandingly important in partitioning energy-rich fuels from muscle, brain, and fat tissue to the activated immune system. Neuroendocrine regulation of fuel allocation has been positively selected as an adaptive programme for transient serious, albeit non-life-threatening, inflammatory episodes. In CARDs, mistakenly, the adaptive programmes are used again but for a much longer time leading to systemic disease sequelae with endocrine (and also neuronal) abnormalities. The major endocrine alterations are depicted in the following list: mild activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system, inadequate secretion of ACTH and cortisol relative to inflammation, loss of androgens, inhibition of the hypothalamic-pituitary-gonadal axis and fertility problems, high serum levels of oestrogens relative to androgens, fat deposits adjacent to inflamed tissue, increase of serum prolactin, and hyperinsulinaemia (and the metabolic syndrome). Neuroendocrine abnormalities are demonstrated using this framework that can explain many CARD-related endocrine disturbances. This chapter gives an overview on pathophysiology of neuroendocrine alterations in the context of energy regulation.
APA, Harvard, Vancouver, ISO, and other styles
4

Miller, Aaron E., Tracy M. DeAngelis, Michelle Fabian, and Ilana Katz Sand. "Confusion, Muscle Cramps, and Weight Loss." In Neuroimmunology. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190693190.003.0024.

Full text
Abstract:
Morvan’s syndrome is a rare autoimmune antibody syndrome causing central, peripheral, and autonomic manifestations. It has been most consistently associated with Caspr2 antibodies, although LGI1 antibodies have also been found in some patients. The Caspr2 protein is located throughout the central and peripheral nervous system. This may account for the diversity of presentations that have been reported in patients with Caspr2 antibodies. The seven core symptoms of Caspr2 antibodies include cognitive dysfunction/seizures, cerebellar symptoms, peripheral nerve hyperexcitability, autonomic dysfunction, insomnia, neuropathic pain, and weight loss. Treatment of Morvan’s syndrome and other Caspr-associated antibody syndromes is largely empirical. Typically, patients are given steroids, intravenous immunoglobulin, and if necessary, other immunosuppressive agents. Prognosis for remission is very good, but relapses may occur.
APA, Harvard, Vancouver, ISO, and other styles
5

Miller, Aaron E., Tracy M. DeAngelis, Michelle Fabian, and Ilana Katz Sand. "Checks and Balances." In Neuroimmunology. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190693190.003.0029.

Full text
Abstract:
In recent years, immune checkpoint inhibitors have been shown to be effective tools in treating multiple types of cancer. In a healthy person, immune checkpoint molecules function to remove self-reactive T cells. However, cancer cells may also use these same pathways to suppress T cells. Checkpoint inhibition brings about non-specific T cell activation, which allows for a tumor-specific immune response. However, an infrequent, but potentially severe, complication of checkpoint inhibitor therapies is the formation of autoimmune conditions. Cases of new or worsened autoimmune conditions have been reported in many organ systems. In the nervous system, central and peripheral processes, as well as disorders of the neuro-muscular junction or muscle, have been identified. Treatment is targeted towards the acute episode. Chronic immunosuppression is usually not initiated because stopping the checkpoint inhibitor therapy will typically abort the autoimmune process. In the future, more of these drugs are likely to be used to treat cancer, and thus more must be known about the mechanisms that induce autoimmunity in this setting and the best strategies to treat them.
APA, Harvard, Vancouver, ISO, and other styles
6

Benarroch, Eduardo E. "Cholinergic Transmission." In Neuroscience for Clinicians, edited by Eduardo E. Benarroch. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190948894.003.0019.

Full text
Abstract:
Acetylcholine (ACh) is a major neurotransmitter in the central and peripheral nervous systems. Cholinergic neurons in the central nervous system include the basal forebrain cholinergic group that projects to the cerebral cortex and has a major role in attention, sensory processing, and memory; the mesopontine group that projects to the thalamus, basal ganglia, and brainstem areas and is involved in arousal, reward, and control of muscle tone; and large aspiny neurons of the striatum controlling basal ganglia function. In the periphery, ACh is the neurotransmitter of motor neurons innervating skeletal muscle; preganglionic neurons innervating autonomic ganglia; and parasympathetic, enteric, and sudomotor sympathetic neurons. Acetylcholine acts via nicotinic receptors to elicit fast excitation and several subtypes of muscarinic receptors that exert a variety of modulatory actions. Given the widespread distribution and targets of ACh, cholinergic systems have a major role in a variety of neurologic disorders, including Alzheimer disease, neuromuscular transmission defects, and autonomic manifestation of autoimmune diseases, drugs, or toxins.
APA, Harvard, Vancouver, ISO, and other styles
7

M. Harvey, Evan, Murad Almasri, and Hugo R. Martinez. "Genetics of Cardiomyopathy." In Cardiomyopathy - Disease of the Heart Muscle [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.97010.

Full text
Abstract:
Cardiomyopathies (CMs) encompass a heterogeneous group of structural and functional (systolic and diastolic) abnormalities of the myocardium and are either confined to the cardiovascular system or are part of a systemic disorder. CMs represent a leading cause of morbidity and mortality and account for a significant percentage of death and cardiac transplantation. The 2006 American Heart Association (AHA) classification grouped CMs into primary (genetic, mixed, or acquired) or secondary (i.e., infiltrative or autoimmune). In 2008, the European Society of Cardiology classification proposed subgrouping CM into familial or genetic and nonfamilial or nongenetic forms. In 2013, the World Heart Federation recommended the MOGES nosology system, which incorporates a morpho-functional phenotype (M), organ(s) involved (O), the genetic inheritance pattern (G), an etiological annotation (E) including genetic defects or underlying disease/substrates, and the functional status (S) of a particular patient based on heart failure symptoms. Rapid advancements in the biology of cardio-genetics have revealed substantial genetic and phenotypic heterogeneity in myocardial disease. Given the variety of disciplines in the scientific and clinical fields, any desired classification may face challenges to obtaining consensus. Nonetheless, the heritable phenotype-based CM classification offers the possibility of a simple, clinically useful diagnostic scheme. In this chapter, we will describe the genetic basis of dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (ACM), LV noncompaction cardiomyopathy (LVNC), and restrictive cardiomyopathy (RCM). Although the descriptive morphologies of these types of CM differ, an overlapping phenotype is frequently encountered within the CM types and arrhythmogenic pathology in clinical practice. CMs appear to originate secondary to disruption of “final common pathways.” These disruptions may have purely genetic causes. For example, single gene mutations result in dysfunctional protein synthesis causing downstream dysfunctional protein interactions at the level of the sarcomere and a CM phenotype. The sarcomere is a complex with multiple protein interactions, including thick myofilament proteins, thin myofilament proteins, and myosin-binding proteins. In addition, other proteins are involved in the surrounding architecture of the sarcomere such as the Z-disk and muscle LIM proteins. One or multiple genes can exhibit tissue-specific function, development, and physiologically regulated patterns of expression for each protein. Alternatively, multiple mutations in the same gene (compound heterozygosity) or in different genes (digenic heterozygosity) may lead to a phenotype that may be classic, more severe, or even overlapping with other disease forms.
APA, Harvard, Vancouver, ISO, and other styles
8

Isenberg, David A., and Ian Giles. "Introduction." In Oxford Textbook of Medicine, edited by Richard A. Watts. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0453.

Full text
Abstract:
About 1 in 20 people develop an autoimmune disease, many of which involve the musculoskeletal system. Young women are particularly at risk, but the development at any age of symptoms such as unexplained fever, rash, polyarthritis, Raynaud’s phenomenon, or mouth ulcers should encourage serological screening for autoimmune rheumatic or vasculitic disorder. The autoimmune rheumatic diseases are a heterogeneous group of disorders characterized by clinical involvement of the joints, connective tissues, muscles, internal organs, Raynaud’s phenomenon, and cutaneous manifestations. They include a broad clinical spectrum of disease, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren’s syndrome, scleroderma, dermatomyositis, polymyositis, antiphospholipid syndrome (APS), and the vasculitides.
APA, Harvard, Vancouver, ISO, and other styles
9

Sultan, Shabina, and David A. Isenberg. "Inflammatory Muscle Diseases: Pathogenesis and Clinical Features." In Handbook of Systemic Autoimmune Diseases. Elsevier, 2004. http://dx.doi.org/10.1016/s1571-5078(04)03007-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Martínez-Jiménez, Santiago. "Other Autoimmune Diseases." In Chest Imaging. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780199858064.003.0062.

Full text
Abstract:
Autoimmune diseases described herein include systemic lupus erythematosus (SLE), dermatomyositis/polymyositis (DM/PM), Sjögren syndrome (SS), and mixed connective tissue disease (MCTD). SLE predominantly affects women of reproductive age. Although pleural involvement is the most common thoracic manifestation, other manifestations include pneumonia, diffuse alveolar hemorrhage and lupus pneumonitis. Interstitial lung disease in patients with SLE include non-specific interstitial pneumonia (NSIP) and usual interstitial pneumonia (UIP). DM/PM affects the skeletal muscle and may frequently result in hypoventilation and respiratory failure (respiratory muscle involvement) and aspiration (laryngeal involvement). Interstitial lung disease is also frequent, and NSIP and organizing pneumonia are the most common patterns. SS typically affects women in the 4th to 5th decades of life. Classic symptoms include xerophtalmia and xerostomia. Interstitial lung disease is among the most common thoracic manifestations; and although NSIP, UIP, organizing pneumonia and amyloidoisis can occur, lymphocytic interstitial pneumonia (LIP) is a characteristic form of interstitial lung disease in SS. MCTD combines clinical features of RS, SLE, PSS and PM/DM. Thoracic involvement typically manifests with pulmonary hypertension and interstitial lung disease (NSIP, UIP and LIP). Pulmonary hypertension can occur in any autoimmune disease and is often associated with a worse prognosis. Chest radiography and thin-section chest CT (or HRCT) are the imaging modalities of choice to detect and assess thoracic manifestations of autoimmune disease.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Autoimmune system; Muscle' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography